Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2013, Article ID 165789, 8 pages
http://dx.doi.org/10.1155/2013/165789
Clinical Study

Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey

1Department of Public Health, Ghent University Hospital, DePintelaan 185, 9000 Ghent, Belgium
2Department of Family Medicine and Cardiology, Lawson Health Research Institute, 801 Commissioners Road East, University of Western Ontario, ON, Canada N6C 5J1
3Preventive Cardiology Clinic, Department of Internal Medicine, Medical University of Sofia, Sofia 1431, Bulgaria
4Rashid Hospital, P.O. Box 4545, Oud Metha Road, Dubai, UAE
5Department of Cardiology, Medical University of Gdañsk, M. Skłodowskiej-Curie 3a Street, 80-210 Gdañsk, Poland
6Clinical Pharmacology Service, INSERM Unit 1048, Faculty of Medicine, University Hospital Toulouse, 1073 Toulouse, France

Received 19 March 2013; Revised 21 May 2013; Accepted 4 June 2013

Academic Editor: Kazuomi Kario

Copyright © 2013 Guy De Backer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Turnbull, “Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: meta-analysis of randomised trials,” British Medical Journal, vol. 336, no. 7653, pp. 1121–1123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Conroy, K. Pyörälä, A. P. Fitzgerald et al., “Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project,” European Heart Journal, vol. 24, no. 11, pp. 987–1003, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. De Backer, R. J. Petrella, A. R. Goudev, G. A. Radaideh, A. Rynkiewicz, and A. Pathak, “Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension,” Fundamental and Clinical Pharmacology, vol. 27, pp. 210–215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Goudev, J.-P. Berrou, and A. Pathak, “Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the POWER observational study,” Vascular Health and Risk Management, vol. 8, pp. 563–568, 2012. View at Google Scholar
  5. E. Von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, and J. P. Vandenbroucke, “The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies,” PLoS Medicine, vol. 4, no. 10, article e296, pp. 1623–1627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Rodondi, T.-H. Collet, D. Nanchen et al., “Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial,” Archives of Internal Medicine, vol. 172, no. 4, pp. 344–352, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Guallar, J. R. Banegas, E. Blasco-Colmenares et al., “Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe—The EURIKA Study,” BMC Public Health, vol. 11, article 704, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Centers for Disease Control and Prevention (CDC), “Vital signs: awareness and treatment of uncontrolled hypertension among adults—United States, 2003–2010,” Morbidity and Mortality Weekly Report, vol. 61, pp. 703–709, 2012. View at Google Scholar
  9. J. R. Banegas, E. López-García, J. Dallongeville et al., “Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study,” European Heart Journal, vol. 32, no. 17, pp. 2143–2152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Missault, N. Witters, and J. Imschoot, “High cardiovascular risk and poor adherence to guidelines in 11 069 patients of middle age and older in primary care centres,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 17, no. 5, pp. 593–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Zannad, G. De Backer, I. Graham et al., “Risk stratification in cardiovascular disease primary prevention—scoring systems, novel markers, and imaging techniques,” Fundamental and Clinical Pharmacology, vol. 26, no. 2, pp. 163–174, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. É. Bruckert, G. Bonnelye, F. Thomas-Delecourt, L. André, and P.-H. Delaage, “Assessment of cardiovascular risk in primary care patients in France Évaluation du risque cardiovasculaire en médecine générale en France,” Archives of Cardiovascular Diseases, vol. 104, no. 6-7, pp. 381–387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. H. Merry, J. M. Boer, L. J. Schouten et al., “Risk prediction of incident coronary heart disease in the Netherlands: re-estimation and improvement of the SCORE risk function,” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 19, pp. 840–848, 2012. View at Google Scholar
  14. T. Sehestedt, J. Jeppesen, T. W. Hansen et al., “Risk prediction is improved by adding markers of subclinical organ damage to SCORE,” European Heart Journal, vol. 31, no. 7, pp. 883–891, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Wierzbicka-Chmiel, K. Mizia-Stec, M. Haberka, A. Chmiel, M. Mizia, and Z. Gasior, “The relationship between cardiovascular risk estimated by use of SCORE system and intima media thickness and flow mediated dilatation in a low risk population,” Cardiology Journal, vol. 16, no. 5, pp. 407–412, 2009. View at Google Scholar · View at Scopus
  16. D. De Bacquer and G. De Backer, “Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality,” International Journal of Cardiology, vol. 143, no. 3, pp. 385–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Rodríguez-Salceda, E. Escortell-Mayor, M. Rico-Blázquez et al., “EDUCORE project: a clinical trial, randomised by clusters, to assess the effect of a visual learning method on blood pressure control in the primary healthcare setting,” BMC Public Health, vol. 10, article 449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Vallès-Fernandez, M. Rosell-Murphy, O. Correcher-Aventin et al., “A quality improvement plan for hypertension control: the INCOTECA Project (Interventions for Control of hypertension in Catalonia),” BMC Public Health, vol. 9, article 89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. B. Shaikh, E. Mathew, J. Sreedharan, J. Muttappallymyalil, S. A. Sharbatti, and S. A. Basha, “Knowledge regarding risk factors of hypertension among entry year students of a medical university,” Journal of Family and Community Medicine, vol. 18, pp. 124–129, 2011. View at Google Scholar